Reuters logo
BRIEF-Capricor Therapeutics q4 loss per share $0.21
2017年3月15日 / 晚上8点46分 / 8 个月前

BRIEF-Capricor Therapeutics q4 loss per share $0.21

March 16 (Reuters) - Capricor Therapeutics Inc

* Capricor Therapeutics reports fourth quarter and full year 2016 financial results and provides corporate update

* Q4 loss per share $0.21

* Capricor Therapeutics- sees cash, cash equivalents, marketable securities will fund research and development programs and other operations into q4 2017

* Capricor Therapeutics Inc - expect janssen decision on its license option for cap-1002 by q3 of 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below